Therapeutic immunotoxins for lymphoid malignancies: the end of the beginning.
Morris
John C
JC
Clinical Trials, Metabolism Branch, Center for Cancer Research, National Cancer Institute, Mark O. Hatfield Clinical Research Center, Bethesda, MD 20892, USA. jmorris@mail.nih.gov
Janik
John E
JE
D000818:Animals; D017321:Clinical Trials, Phase I as Topic / Q000639:trends; D004353:Drug Evaluation, Preclinical; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*
D000922:Immunotoxins